{"title":"[Tanshinone reverses androgen deprivation-induced invasion of prostate cancer cells by suppressing PI3K and AKT signaling pathways].","authors":"Man-Yao Ma, Wen Xu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the effect of tanshinone on the invasion of PCa cells induced by androgen-deprivation therapy (ADT) and its possible action mechanism.</p><p><strong>Methods: </strong>We treated human PCa LNCaP cells with tanshinone at 0 nmol/L (the control group), 5 nmol/L (tanshinone group 1), 10 nmol/L (tanshinone group 2) and 20 nmol/L (tanshinone group 3), respectively. Then we detected their cloning, angiogenesis and invasion abilities by plate cloning assay, tube-formation assay and Transwell chamber assay, respectively, examined their apoptosis using the AnnexinV-FITC/PI double staining method, and determined the protein expressions of phosphatidylinositol 3-kinase (PI3K), p-PI3K, protein kinase B (AKT) and p-AKT by Western blot.</p><p><strong>Results: </strong>Compared with the control group, the PCa LNCaP cells in the tanshinone groups 1, 2 and 3 showed significant dose-dependent decreases in the clone formation rate ([25.14 ± 5.19]% vs [19.33 ± 4.12]% vs [14.69 ± 4.71]% vs [9.35 ± 2.37]%, P<0.05), number of cellular lumens ([23.20 ± 4.85] vs [19.80 ± 5.12] vs [14.40 ± 4.16] vs [10.20 ± 3.21] per microscopic field, P<0.05) and count of transmembrane cells ([62.80 ± 8.97] vs [50.40 ± 7.62] vs [38.60 ± 5.16] vs [27.40 ± 4.91] per microscopic field, P<0.05), increase in the rate of cell apoptosis ([3.58 ± 0.74]% vs [8.97 ± 1.36]% vs [14.64 ± 4.10]% vs [21.17 ± 5.37]%, P<0.05), and down-regulation of the expressions of p-PI3K, PI3K, p-AKT and AKT (P<0.05).</p><p><strong>Conclusion: </strong>Tanshinone can reverse ADT-induced invasion of PCa cells, reduce their clone formation and angiogenesis, promote their apoptosis, and inhibit the activity of PI3K and AKT signaling pathways.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"30 2","pages":"104-110"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华男科学杂志","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To explore the effect of tanshinone on the invasion of PCa cells induced by androgen-deprivation therapy (ADT) and its possible action mechanism.
Methods: We treated human PCa LNCaP cells with tanshinone at 0 nmol/L (the control group), 5 nmol/L (tanshinone group 1), 10 nmol/L (tanshinone group 2) and 20 nmol/L (tanshinone group 3), respectively. Then we detected their cloning, angiogenesis and invasion abilities by plate cloning assay, tube-formation assay and Transwell chamber assay, respectively, examined their apoptosis using the AnnexinV-FITC/PI double staining method, and determined the protein expressions of phosphatidylinositol 3-kinase (PI3K), p-PI3K, protein kinase B (AKT) and p-AKT by Western blot.
Results: Compared with the control group, the PCa LNCaP cells in the tanshinone groups 1, 2 and 3 showed significant dose-dependent decreases in the clone formation rate ([25.14 ± 5.19]% vs [19.33 ± 4.12]% vs [14.69 ± 4.71]% vs [9.35 ± 2.37]%, P<0.05), number of cellular lumens ([23.20 ± 4.85] vs [19.80 ± 5.12] vs [14.40 ± 4.16] vs [10.20 ± 3.21] per microscopic field, P<0.05) and count of transmembrane cells ([62.80 ± 8.97] vs [50.40 ± 7.62] vs [38.60 ± 5.16] vs [27.40 ± 4.91] per microscopic field, P<0.05), increase in the rate of cell apoptosis ([3.58 ± 0.74]% vs [8.97 ± 1.36]% vs [14.64 ± 4.10]% vs [21.17 ± 5.37]%, P<0.05), and down-regulation of the expressions of p-PI3K, PI3K, p-AKT and AKT (P<0.05).
Conclusion: Tanshinone can reverse ADT-induced invasion of PCa cells, reduce their clone formation and angiogenesis, promote their apoptosis, and inhibit the activity of PI3K and AKT signaling pathways.
期刊介绍:
National journal of andrology was founded in June 1995. It is a core journal of andrology and reproductive medicine, published monthly, and is publicly distributed at home and abroad. The main columns include expert talks, monographs (basic research, clinical research, evidence-based medicine, traditional Chinese medicine), reviews, clinical experience exchanges, case reports, etc. Priority is given to various fund-funded projects, especially the 12th Five-Year National Support Plan and the National Natural Science Foundation funded projects. This journal is included in about 20 domestic databases, including the National Science and Technology Paper Statistical Source Journal (China Science and Technology Core Journal), the Source Journal of the China Science Citation Database, the Statistical Source Journal of the China Academic Journal Comprehensive Evaluation Database (CAJCED), the Full-text Collection Journal of the China Journal Full-text Database (CJFD), the Overview of the Chinese Core Journals (2017 Edition), and the Source Journal of the Top Academic Papers of China's Fine Science and Technology Journals (F5000). It has been included in the full text of the American Chemical Abstracts, the American MEDLINE, the American EBSCO, and the database.